Sugar.

Table sugar is sucrose, and sucrase splits it into glucose and fructose before either can be absorbed. The disaccharide itself does not cross the mucosa.

Iminosugars from mulberry leaf compete with sugar at the brush border sucrase-isomaltase site. Hydrolysis slows, and glucose enters the circulation over a longer window.

Gymnemic acids bind the sweet taste receptor, so sugar tasted afterwards reads as flat for a period. This is a taste-side interaction and does not change how the sugar is handled downstream.

Glucose from sugar is processed through pyruvate dehydrogenase and the pentose phosphate pathway, both of which run on thiamine pyrophosphate. A higher sugar intake raises the thiamine the body has to supply to those enzymes.

A viscous guar solution slows how fast sugar leaves the stomach and diffuses to the brush border. The peak in blood glucose after the same sugar dose is lower and later.

Psyllium forms a gel that raises the viscosity of gut contents and slows diffusion of dissolved sugars to the absorptive surface. Total absorption is largely unchanged, the rate is not.

Steviol glycosides replace most of the sweetening mass, while a small amount of sugar rounds out the profile and covers the licorice-like tail. Formulators use the pair to cut sugar without losing taste.

Glucose crosses the small-intestine brush border on SGLT1, a carrier that moves sodium and glucose together. Sodium is what drives the transport, which is why oral rehydration formulas pair a sugar with a sodium salt rather than using either alone. Water follows the absorbed solutes. The pairing is standard formulation practice in rehydration products.

Carbohydrate-electrolyte drinks combine a sugar with sodium, potassium, chloride and often magnesium. The sugar supplies transportable carbohydrate during activity and supports fluid uptake through sodium-coupled transport; the electrolytes replace what is lost in sweat. Concentration matters, since a very concentrated sugar solution slows gastric emptying. Read this as formulation convention with a mechanistic basis.

Creatine enters muscle through a sodium-dependent transporter whose activity is increased by insulin. Co-ingesting a simple sugar raises circulating insulin and has been used in loading protocols for that reason. The effect is on muscle uptake, a marker of retention rather than a performance outcome on its own.

Carbohydrate plus a rapidly digested protein raises the insulin response above either alone, and insulin drives both glucose uptake for glycogen resynthesis and amino acid transport into muscle. Recovery formulas pair the two for that reason. What is measured in most work is substrate handling, not a downstream performance outcome.

Dehydroascorbate, the oxidised form of vitamin C, shares GLUT-family transporters with glucose, so high glucose concentrations compete with its cellular uptake. The interaction sits at the transporter, and it is the reason vitamin C uptake is described as glucose-sensitive in cell physiology. This is mechanistic pharmacology rather than a demonstrated clinical effect of eating sugar with a vitamin C supplement.

Chromium is described in nutrition monographs as participating in insulin signalling, and trials of chromium supplements typically read out glucose and insulin markers after a carbohydrate load. The measured endpoints are markers, not clinical outcomes. Effect sizes across the literature are inconsistent, which is why this sits at a middling confidence.

Cinnamon extracts have been studied for their effect on glucose readings taken after a carbohydrate meal, with mixed results across preparations and doses. Where an effect appears it is on a blood marker measured over hours. Anyone already using medication that lowers blood sugar should raise the combination with a clinician, since the direction of effect is the same.

Berberine activates AMPK and has been studied for its effect on fasting and post-load glucose readings. Taken alongside a sugar load the two act in opposite directions on the same marker. The additive direction matters most for people already on glucose-lowering medication, who should discuss it with a clinician.

Glucomannan forms a viscous gel in the stomach and upper intestine that slows gastric emptying and the rate at which sugars reach the absorptive surface. The total amount absorbed changes little; the shape of the post-meal glucose curve is what moves. Adequate fluid is needed with any viscous fibre.

Oat beta-glucan raises the viscosity of gut contents, which slows the delivery of digested sugars to the intestinal wall and blunts the post-meal rise in blood glucose. The effect depends on molecular weight and on the dose being eaten in the same meal as the carbohydrate. This is a marker measurement across a few hours.

Pectin gels in the gut lumen and slows the diffusion of sugars towards the mucosa, flattening the rise in blood glucose after a sweet meal. It also ferments in the colon to short-chain fatty acids. The glycaemic part is a rate effect, not a reduction in the calories absorbed.

Resistant starch escapes amylase digestion in the small intestine and ferments in the colon, so it contributes little to the glucose that appears in blood. Replacing part of the rapidly digested carbohydrate in a food changes the post-meal glucose profile. The colonic fermentation yields short-chain fatty acids, butyrate among them.

Inulin is a fructan that human enzymes cannot hydrolyse, so it passes to the colon and feeds saccharolytic bacteria instead of contributing absorbable sugar. Formulators use it to replace part of the sugar mass in a product while keeping bulk and some sweetness. Larger doses commonly produce gas and bloating.

Bitter melon has a long traditional record and small human trials that read out fasting and post-meal glucose. The trials are small and heterogeneous in preparation and dose. The direction of effect overlaps with glucose-lowering medication, which is worth a clinician conversation.

Lipoic acid is the covalently bound cofactor of the pyruvate dehydrogenase and alpha-ketoglutarate dehydrogenase complexes, the entry points for glucose-derived carbon into the citric acid cycle. Carbohydrate oxidation runs through those complexes. The supplemental free form is largely a redox agent rather than a top-up of the enzyme-bound pool, which is a distinction often blurred in marketing copy.

Lactic acid bacteria ferment simple sugars to organic acids, which is the basis of both fermented foods and the acid produced by oral bacteria on tooth surfaces. Sugar in a formula is the substrate; the organism determines the products. Formulators also use sugars and sugar alcohols as cryoprotectants in probiotic powders.

Every kinase step in glycolysis, hexokinase and phosphofructokinase included, uses ATP complexed with magnesium as the true substrate. Carbohydrate metabolism therefore runs on a magnesium-dependent set of enzymes. This is textbook biochemistry rather than a claim that adding magnesium to a sugary drink does anything measurable.